Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 10, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 15, 2026
OfficerTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-390624
Filed / recorded
Sep 15, 2026, 12:24 AM UTC
Added to OQRO
Oct 8, 2026, 12:20 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
BridgeBio Oncology Therapeutics, Inc.
Issuer CIK
1869105
Ticker
BBOT
Reporting person
Marc Cobo
Relationship
Officer
Officer title
Principal Accounting Officer
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Sep 10, 2026
Transaction code
F
Shares / units
203
Price per share
$5.52
Acquired / disposed
Disposed (D)
Shares owned after
14,141
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of RSUs.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.